C

Compass Therapeutics
D

CMPX

2.93000
USD
-0.16
(-5.18%)
Market Closed
Volume
46,090
EPS
-0
Div Yield
-
P/E
-8
Market Cap
403,136,271
OverviewSignalsIdeasNews
Related Instruments
    XEMUSD
    XEMUSD
    0.000339
    (1.52%)
    0.022434 USD
    AEM
    AEM
    -1.904
    (-1.94%)
    96.120 USD
    A
    AG
    -0.20500
    (-3.56%)
    5.55500 USD
    FNV
    FNV
    -2.990
    (-2.11%)
    138.690 USD
    F
    FSM
    -0.40000
    (-8.30%)
    4.42000 USD
    GOLD
    GOLD
    -0.510
    (-2.71%)
    18.310 USD
    N
    NEM
    -2.770
    (-5.76%)
    45.340 USD
    S
    SSRM
    -0.255
    (-2.43%)
    10.240 USD
    More
News

Title: Compass Therapeutics

Sector: Healthcare
Industry: Biotechnology
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.